Search

everythinglearnresearchcommunity

for

Search:↓

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Targeting thyroid hormone receptor α in liver cells may help treat liver fibrosis.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Endothelial TLR2 is crucial for timely wound healing, but HFSC TLR2 is not needed.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Losing Memo protein shortens lifespan and affects health.

Darkened knuckles can be an early sign of insulin resistance.

NIPP1 is important for healthy skin and could help treat skin inflammation.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Deleting NIPP1 in mouse skin cells causes early aging and chronic skin issues.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

Tofacitinib treatment is used for teenagers with alopecia areata.

Nail loss may be a side effect of the MS drug teriflunomide.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Iron contributes to skin fibrosis in nephrogenic systemic fibrosis.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Nerve growth factor helps cashmere goat hair cells grow by activating a specific protein.

Reducing Flightless I protein improves wound healing by activating skin stem cells.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.